Table: Rohto -Q1 group results

Rohto Pharmaceutical

07/08/2024 07:02

Aug 7 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2024        Jun 30, 2023     Mar 31, 2025 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               68.36               61.17           320.00    
                   (+11.7 pct)         (+17.1 pct)      (+18.2 pct) 
  Operating           11.79               11.29            43.20    
                   (+4.4 pct)          (+36.1 pct)      (+7.9 pct)  
  Recurring           12.27               12.24            44.20    
                   (+0.2 pct)          (+26.9 pct)      (+4.2 pct)  
  Net                  8.48                9.09            32.20    
                   (-6.7 pct)          (+30.0 pct)      (+4.1 pct)  
  EPS               37.18 yen           39.85 yen       141.14 yen  
  EPS Diluted       37.08 yen           39.73 yen                   
  Ann Div                               27.00 yen        33.00 yen  
  -Q2 div                               12.00 yen        16.00 yen  
  -Q4 div                               15.00 yen        17.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T